Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Reata Pharmaceuticals Inc (RETA) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Reata Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1358762.
Total stock buying since 2016: $137,780,000.
Total stock sales since 2016: $162,882,374.
Total stock option exercises since 2016: $2,763,027.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 526,002 | $57,289,784 | 80,537 | $2,763,027 |
| 2021 | 16,000 | $419,568 | 20,000 | $2,674,411 | 0 | $0 |
| 2020 | 3,000 | $300,615 | 258,586 | $44,546,057 | 0 | $0 |
| 2019 | 120,654 | $22,079,682 | 332,638 | $35,459,212 | 0 | $0 |
| 2018 | 335,933 | $19,953,520 | 64,336 | $3,008,775 | 0 | $0 |
| 2017 | 744,552 | $18,622,013 | 823,000 | $19,904,135 | 0 | $0 |
| 2016 | 5,074,080 | $76,404,602 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-09 | 0 | $0 | 3,581 | $614,874 | 0 | $0 |
| 2023-07 | 0 | $0 | 128,235 | $21,105,043 | 8,235 | $759,267 |
| 2023-06 | 0 | $0 | 85,139 | $8,742,396 | 26,562 | $725,673 |
| 2023-05 | 0 | $0 | 39,879 | $3,387,880 | 0 | $0 |
| 2023-03 | 0 | $0 | 269,168 | $23,439,591 | 45,740 | $1,278,087 |
| 2021-12 | 16,000 | $419,568 | 0 | $0 | 0 | $0 |
| 2021-06 | 0 | $0 | 10,000 | $1,428,941 | 0 | $0 |
| 2021-05 | 0 | $0 | 10,000 | $1,245,470 | 0 | $0 |
| 2020-11 | 0 | $0 | 254,586 | $43,869,477 | 0 | $0 |
| 2020-08 | 3,000 | $300,615 | 0 | $0 | 0 | $0 |
| 2020-06 | 0 | $0 | 2,000 | $287,940 | 0 | $0 |
| 2020-03 | 0 | $0 | 2,000 | $388,640 | 0 | $0 |
| 2019-12 | 0 | $0 | 12,000 | $2,428,370 | 0 | $0 |
| 2019-11 | 120,654 | $22,079,682 | 9,591 | $2,027,223 | 0 | $0 |
| 2019-10 | 0 | $0 | 65,000 | $9,376,735 | 0 | $0 |
| 2019-09 | 0 | $0 | 65,000 | $5,626,115 | 0 | $0 |
| 2019-08 | 0 | $0 | 4,000 | $293,136 | 0 | $0 |
| 2019-07 | 0 | $0 | 4,000 | $339,060 | 0 | $0 |
| 2019-06 | 0 | $0 | 6,000 | $504,460 | 0 | $0 |
| 2019-05 | 0 | $0 | 4,000 | $359,020 | 0 | $0 |
| 2019-04 | 0 | $0 | 6,000 | $516,232 | 0 | $0 |
| 2019-03 | 0 | $0 | 70,380 | $6,897,547 | 0 | $0 |
| 2019-02 | 0 | $0 | 48,232 | $4,332,164 | 0 | $0 |
| 2019-01 | 0 | $0 | 38,435 | $2,759,150 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-14 | Loewen Andrea (SVP, Global Regulatory Affairs) | Sale | 3,175 | 172.03 | 546,179 |
| 2023-09-05 | Anand Bhaskar (SVP, Chief Accounting Officer) | Sale | 406 | 169.20 | 68,695 |
| 2023-07-28 | Mcclellan William D. Jr. (Director) | Sale | 5,000 | 164.49 | 822,440 |
| 2023-07-28 | Bir Dawn Carter (Chief Commercial Officer) | Sale | 40,000 | 164.54 | 6,581,440 |
| 2023-07-28 | Ruff Shamim (Director) | Sale | 8,235 | 164.53 | 1,354,888 |
| 2023-07-28 | Ruff Shamim (Director) | Option Ex | 8,235 | 92.20 | 759,267 |
| 2023-07-28 | Soni Manmeet Singh (COO, CFO and President) | Sale | 75,000 | 164.62 | 12,346,275 |
| 2023-06-14 | Anand Bhaskar (SVP, Chief Accounting Officer) | Sale | 2,343 | 102.11 | 239,248 |
| 2023-06-14 | Anand Bhaskar (SVP, Chief Accounting Officer) | Option Ex | 1,562 | 27.32 | 42,673 |
| 2023-06-13 | Soni Manmeet Singh (COO, CFO and President) | Sale | 78,085 | 102.89 | 8,033,853 |
| 2023-06-13 | Soni Manmeet Singh (COO, CFO and President) | Option Ex | 25,000 | 27.32 | 683,000 |
| 2023-06-12 | Soni Manmeet Singh (COO, CFO and President) | Sale | 4,711 | 99.62 | 469,295 |
| 2023-05-16 | Khan Samina (SVP, Chief Medical Officer) | Sale | 352 | 81.37 | 28,641 |
| 2023-05-16 | Anand Bhaskar (SVP, Chief Accounting Officer) | Sale | 136 | 81.10 | 11,030 |
| 2023-05-16 | Bir Dawn Carter (Chief Commercial Officer) | Sale | 417 | 80.95 | 33,758 |
| 2023-05-16 | Meyer Colin John (Chief Innovation Officer) | Sale | 625 | 80.94 | 50,590 |
| 2023-05-16 | Loewen Andrea (SVP, Global Regulatory Affairs) | Sale | 313 | 81.02 | 25,359 |
| 2023-05-16 | Soni Manmeet Singh (COO, CFO and President) | Sale | 625 | 80.93 | 50,583 |
| 2023-05-16 | Wortley Michael D (Chief Legal Officer) | Sale | 417 | 80.99 | 33,773 |
| 2023-05-15 | Khan Samina (SVP, Chief Medical Officer) | Sale | 288 | 85.32 | 24,572 |
| 2023-05-15 | Anand Bhaskar (SVP, Chief Accounting Officer) | Sale | 950 | 85.98 | 81,683 |
| 2023-05-15 | Bir Dawn Carter (Chief Commercial Officer) | Sale | 894 | 85.09 | 76,070 |
| 2023-05-15 | Meyer Colin John (Chief Innovation Officer) | Sale | 5,608 | 85.27 | 478,166 |
| 2023-05-15 | Loewen Andrea (SVP, Global Regulatory Affairs) | Sale | 103 | 84.71 | 8,725 |
| 2023-05-15 | Soni Manmeet Singh (COO, CFO and President) | Sale | 21,507 | 84.94 | 1,826,847 |
| 2023-05-15 | Wortley Michael D (Chief Legal Officer) | Sale | 894 | 84.81 | 75,815 |
| 2023-05-12 | Loewen Andrea (SVP, Global Regulatory Affairs) | Sale | 6,750 | 86.26 | 582,268 |
| 2023-03-13 | Bir Dawn Carter (Chief Commercial Officer) | Sale | 9,317 | 86.77 | 808,436 |
| 2023-03-10 | Ruff Shamim (Director) | Sale | 5,740 | 83.73 | 480,610 |
| 2023-03-10 | Ruff Shamim (Director) | Option Ex | 5,740 | 32.28 | 185,287 |
| 2023-03-07 | Khan Samina (SVP, Chief Medical Officer) | Sale | 3,961 | 83.46 | 330,585 |
| 2023-03-07 | Anand Bhaskar (SVP, Chief Accounting Officer) | Sale | 165 | 84.58 | 13,955 |
| 2023-03-07 | Bir Dawn Carter (Chief Commercial Officer) | Sale | 42,042 | 85.88 | 3,610,693 |
| 2023-03-07 | Meyer Colin John (Chief Innovation Officer) | Sale | 621 | 84.57 | 52,517 |
| 2023-03-07 | Loewen Andrea (SVP, Global Regulatory Affairs) | Sale | 19,036 | 83.90 | 1,597,120 |
| 2023-03-07 | Loewen Andrea (SVP, Global Regulatory Affairs) | Option Ex | 15,000 | 27.32 | 409,800 |
| 2023-03-07 | Soni Manmeet Singh (COO, CFO and President) | Sale | 622 | 84.69 | 52,680 |
| 2023-03-07 | Wortley Michael D (Chief Legal Officer) | Sale | 414 | 84.46 | 34,966 |
| 2023-03-06 | Bir Dawn Carter (Chief Commercial Officer) | Sale | 54,954 | 89.78 | 4,933,770 |
| 2023-03-03 | Khan Samina (SVP, Chief Medical Officer) | Sale | 2,813 | 87.36 | 245,743 |
| 2023-03-03 | Anand Bhaskar (SVP, Chief Accounting Officer) | Sale | 820 | 87.47 | 71,725 |
| 2023-03-03 | Bir Dawn Carter (Chief Commercial Officer) | Sale | 2,166 | 88.25 | 191,147 |
| 2023-03-03 | Meyer Colin John (Chief Innovation Officer) | Sale | 5,286 | 87.35 | 461,732 |
| 2023-03-03 | Loewen Andrea (SVP, Global Regulatory Affairs) | Sale | 1,601 | 87.73 | 140,455 |
| 2023-03-03 | Soni Manmeet Singh (COO, CFO and President) | Sale | 3,587 | 87.97 | 315,548 |
| 2023-03-03 | Wortley Michael D (Chief Legal Officer) | Sale | 2,169 | 87.57 | 189,939 |
| 2023-03-02 | Khan Samina (SVP, Chief Medical Officer) | Sale | 25,000 | 84.70 | 2,117,500 |
| 2023-03-02 | Khan Samina (SVP, Chief Medical Officer) | Option Ex | 25,000 | 27.32 | 683,000 |
| 2023-03-02 | Meyer Colin John (Chief Innovation Officer) | Sale | 88,636 | 87.67 | 7,770,718 |
| 2023-03-02 | Loewen Andrea (SVP, Global Regulatory Affairs) | Sale | 218 | 90.61 | 19,752 |
| 2021-12-31 | Soni Manmeet Singh (COO and CFO) | Buy | 16,000 | 26.22 | 419,568 |
| 2021-06-09 | Castellanos Elaine (VP, Chief Accounting Officer) | Sale | 8,454 | 142.18 | 1,201,964 |
| 2021-06-07 | Castellanos Elaine (VP, Chief Accounting Officer) | Sale | 1,546 | 146.82 | 226,977 |
| 2021-05-26 | Castellanos Elaine (VP, Chief Accounting Officer) | Sale | 10,000 | 124.55 | 1,245,470 |
| 2020-11-17 | Meyer Colin John (Chief Research Officer) | Sale | 6,395 | 166.60 | 1,065,432 |
| 2020-11-16 | Meyer Colin John (Chief Research Officer) | Sale | 18,605 | 173.03 | 3,219,278 |
| 2020-11-12 | Mcclellan William D. Jr. (Director) | Sale | 4,000 | 173.49 | 693,964 |
| 2020-11-12 | Castellanos Elaine (VP, Chief Accounting Officer) | Sale | 3,500 | 176.02 | 616,070 |
| 2020-11-11 | Wortley Michael D (Chief Legal Officer) | Sale | 51,429 | 180.02 | 9,258,351 |
| 2020-11-10 | Huff James Warren (Chief Executive Officer) | Sale | 64,970 | 175.00 | 11,369,750 |
| 2020-11-09 | Mcclellan William D. Jr. (Director) | Sale | 4,000 | 150.01 | 600,040 |
| 2020-11-09 | Bir Dawn Carter (Chief Commercial Officer) | Sale | 60,000 | 162.50 | 9,750,300 |
| 2020-11-09 | Huff James Warren (Chief Executive Officer) | Sale | 16,687 | 175.06 | 2,921,292 |
| 2020-11-09 | Meyer Colin John (Chief Research Officer) | Sale | 25,000 | 175.00 | 4,375,000 |
| 2020-08-14 | Soni Manmeet Singh (COO and CFO) | Buy | 3,000 | 100.20 | 300,615 |
| 2020-06-01 | Castellanos Elaine (VP, Chief Accounting Officer) | Sale | 2,000 | 143.97 | 287,940 |
| 2020-03-02 | Castellanos Elaine (VP, Chief Accounting Officer) | Sale | 2,000 | 194.32 | 388,640 |
| 2019-12-16 | Wilson Jason Douglas (Executive VP of Operations) | Sale | 10,000 | 203.99 | 2,039,890 |
| 2019-12-02 | Castellanos Elaine (VP, Chief Accounting Officer) | Sale | 2,000 | 194.24 | 388,480 |
| 2019-11-20 | Evelyn Potter Rose Survivor's Trust (Other) | Sale | 6,591 | 213.12 | 1,404,673 |
| 2019-11-19 | Evelyn Potter Rose Survivor's Trust (Other) | Sale | 2,000 | 210.00 | 420,000 |
| 2019-11-18 | Evelyn Potter Rose Survivor's Trust (Other) | Sale | 1,000 | 202.55 | 202,550 |
| 2019-11-18 | Traweek James W Jr | Buy | 40,218 | 183.00 | 7,359,894 |
| 2019-11-18 | Mcgaughy R Kent Jr | Buy | 40,218 | 183.00 | 7,359,894 |
| 2019-11-18 | Cpmg Inc | Buy | 40,218 | 183.00 | 7,359,894 |
| 2019-10-28 | Castellanos Elaine (VP, Chief Accounting Officer) | Sale | 4,000 | 200.00 | 800,000 |
| 2019-10-25 | Castellanos Elaine (VP, Chief Accounting Officer) | Sale | 2,000 | 190.00 | 380,000 |
| 2019-10-18 | Castellanos Elaine (Principal Accounting Officer) | Sale | 2,000 | 170.00 | 340,000 |
| 2019-10-17 | Wilson Jason Douglas (Executive VP of Operations) | Sale | 10,000 | 170.00 | 1,700,000 |
| 2019-10-15 | Castellanos Elaine (Principal Accounting Officer) | Sale | 14,000 | 152.76 | 2,138,640 |
| 2019-10-15 | Wilson Jason Douglas (Executive VP of Operations) | Sale | 15,000 | 146.87 | 2,203,095 |
| 2019-10-14 | Castellanos Elaine (Principal Accounting Officer) | Sale | 3,000 | 105.00 | 315,000 |
| 2019-10-14 | Wilson Jason Douglas (Executive VP of Operations) | Sale | 15,000 | 100.00 | 1,500,000 |
| 2019-09-27 | Huff James Warren (Chief Executive Officer) | Sale | 63,000 | 86.61 | 5,456,115 |
| 2019-09-06 | Castellanos Elaine (Principal Accounting Officer) | Sale | 2,000 | 85.00 | 170,000 |
| 2019-08-15 | Wilson Jason Douglas (Chief Financial Officer) | Sale | 4,000 | 73.28 | 293,136 |
| 2019-07-15 | Wilson Jason Douglas (Chief Financial Officer) | Sale | 4,000 | 84.77 | 339,060 |
| 2019-06-17 | Wilson Jason Douglas (Chief Financial Officer) | Sale | 4,000 | 83.52 | 334,060 |
| 2019-06-03 | Castellanos Elaine (Principal Accounting Officer) | Sale | 2,000 | 85.20 | 170,400 |
| 2019-05-15 | Wilson Jason Douglas (Chief Financial Officer) | Sale | 4,000 | 89.75 | 359,020 |
| 2019-04-15 | Wilson Jason Douglas (Chief Financial Officer) | Sale | 4,000 | 83.97 | 335,892 |
| 2019-04-08 | Castellanos Elaine (Principal Accounting Officer) | Sale | 2,000 | 90.17 | 180,340 |
| 2019-03-19 | Wilson Jason Douglas (Chief Financial Officer) | Sale | 28,396 | 94.51 | 2,683,649 |
| 2019-03-18 | Wilson Jason Douglas (Chief Financial Officer) | Sale | 1,604 | 95.11 | 152,556 |
| 2019-03-15 | Wilson Jason Douglas (Chief Financial Officer) | Sale | 4,000 | 93.62 | 374,468 |
| 2019-03-05 | Castellanos Elaine (Principal Accounting Officer) | Sale | 3,588 | 102.00 | 365,976 |
| 2019-03-05 | Bass James Edward (Director) | Sale | 5,852 | 100.29 | 586,920 |
| 2019-03-05 | Wortley Michael D (Chief Legal Officer) | Sale | 26,940 | 101.48 | 2,733,978 |
| 2019-02-26 | Ward Keith Wayne (Chief Development Officer) | Sale | 25,184 | 91.31 | 2,299,551 |
| 2019-02-25 | Ward Keith Wayne (Chief Development Officer) | Sale | 15,183 | 91.00 | 1,381,653 |
| 2019-02-15 | Wilson Jason Douglas (Chief Financial Officer) | Sale | 4,000 | 85.44 | 341,760 |
| 2019-02-05 | Wilson Jason Douglas (Chief Financial Officer) | Sale | 3,000 | 80.00 | 240,000 |
| 2019-02-01 | Wilson Jason Douglas (Chief Financial Officer) | Sale | 865 | 80.00 | 69,200 |
| 2019-01-31 | Wilson Jason Douglas (Chief Financial Officer) | Sale | 6,135 | 80.00 | 490,800 |
| 2019-01-31 | Ward Keith Wayne (Chief Development Officer) | Sale | 4,150 | 76.57 | 317,765 |
| 2019-01-15 | Wilson Jason Douglas (Chief Financial Officer) | Sale | 4,000 | 71.27 | 285,064 |
| 2019-01-07 | Wilson Jason Douglas (Chief Financial Officer) | Sale | 20,000 | 72.04 | 1,440,820 |
| 2019-01-02 | Ward Keith Wayne (Chief Development Officer) | Sale | 4,150 | 54.15 | 224,701 |
| 2018-12-20 | Bass James Edward (Director) | Buy | 888 | 52.12 | 46,287 |
| 2018-12-12 | Traweek James W Jr | Buy | 1,418 | 59.90 | 84,931 |
| 2018-12-12 | Mcgaughy R Kent Jr | Buy | 1,418 | 59.90 | 84,931 |
| 2018-12-12 | Cpmg Inc | Buy | 1,418 | 59.90 | 84,931 |
| 2018-12-11 | Traweek James W Jr | Buy | 52,809 | 60.07 | 3,172,342 |
| 2018-12-11 | Mcgaughy R Kent Jr | Buy | 52,809 | 60.07 | 3,172,342 |
| 2018-12-11 | Cpmg Inc | Buy | 52,809 | 60.07 | 3,172,342 |
| 2018-12-10 | Traweek James W Jr | Buy | 56,599 | 58.70 | 3,322,078 |
| 2018-12-10 | Mcgaughy R Kent Jr | Buy | 56,599 | 58.70 | 3,322,078 |
| 2018-12-10 | Cpmg Inc | Buy | 56,599 | 58.70 | 3,322,078 |
| 2018-11-16 | Bass James Edward (Director) | Buy | 1,679 | 59.33 | 99,615 |
| 2018-11-07 | Ward Keith Wayne (Chief Development Officer) | Sale | 4,750 | 67.39 | 320,078 |
| 2018-11-01 | Ward Keith Wayne (Chief Development Officer) | Sale | 4,750 | 59.48 | 282,530 |
| 2018-10-23 | Ward Keith Wayne (Chief Development Officer) | Sale | 14,250 | 57.08 | 813,390 |
| 2018-07-25 | Bass James Edward (Director) | Buy | 888 | 78.34 | 69,565 |
| 2018-07-23 | Castellanos Elaine (Principal Accounting Officer) | Sale | 7,336 | 51.14 | 375,163 |
| 2018-07-05 | Ward Keith Wayne (Chief Development Officer) | Sale | 4,750 | 36.62 | 173,945 |
| 2018-06-05 | Ward Keith Wayne (Chief Development Officer) | Sale | 28,500 | 36.62 | 1,043,669 |
| 2017-12-29 | Traweek James W Jr | Buy | 17,000 | 28.47 | 484,024 |
| 2017-12-29 | Mcgaughy R Kent Jr | Buy | 17,000 | 28.47 | 484,024 |
| 2017-12-29 | Cpmg Inc | Buy | 17,000 | 28.47 | 484,024 |
| 2017-12-28 | Traweek James W Jr | Buy | 200 | 26.10 | 5,220 |
| 2017-12-28 | Mcgaughy R Kent Jr | Buy | 200 | 26.10 | 5,220 |
| 2017-12-28 | Cpmg Inc | Buy | 200 | 26.10 | 5,220 |
| 2017-12-27 | Traweek James W Jr | Buy | 15,000 | 25.83 | 387,450 |
| 2017-12-27 | Mcgaughy R Kent Jr | Buy | 15,000 | 25.83 | 387,450 |
| 2017-12-27 | Cpmg Inc | Buy | 15,000 | 25.83 | 387,450 |
| 2017-12-26 | Traweek James W Jr | Buy | 12,000 | 26.06 | 312,732 |
| 2017-12-26 | Mcgaughy R Kent Jr | Buy | 12,000 | 26.06 | 312,732 |
| 2017-12-26 | Cpmg Inc | Buy | 12,000 | 26.06 | 312,732 |
| 2017-12-14 | Traweek James W Jr | Buy | 78,275 | 24.65 | 1,929,713 |
| 2017-12-14 | Mcgaughy R Kent Jr | Buy | 78,275 | 24.65 | 1,929,713 |
| 2017-12-14 | Cpmg Inc | Buy | 78,275 | 24.65 | 1,929,713 |
| 2017-12-13 | Traweek James W Jr | Buy | 121,725 | 24.43 | 2,973,741 |
| 2017-12-13 | Mcgaughy R Kent Jr | Buy | 121,725 | 24.43 | 2,973,741 |
| 2017-12-13 | Cpmg Inc | Buy | 121,725 | 24.43 | 2,973,741 |
| 2017-11-15 | Bass James Edward (Director) | Buy | 3,888 | 24.02 | 93,389 |
| 2017-08-01 | Bass James Edward (Director) | Buy | 8,064 | 31.00 | 249,984 |
| 2017-06-14 | Novo A/s (10% Owner) | Sale | 49,611 | 25.03 | 1,241,862 |
| 2017-06-13 | Novo A/s (10% Owner) | Sale | 11,389 | 25.47 | 290,077 |
| 2017-06-12 | Novo A/s (10% Owner) | Sale | 90,303 | 25.28 | 2,282,859 |
| 2017-06-09 | Novo A/s (10% Owner) | Sale | 2,200 | 25.89 | 56,955 |
| 2017-06-08 | Novo A/s (10% Owner) | Sale | 130,000 | 26.00 | 3,380,000 |
| 2017-06-07 | Novo A/s (10% Owner) | Sale | 2,000 | 28.04 | 56,080 |
| 2017-06-06 | Novo A/s (10% Owner) | Sale | 64,170 | 28.09 | 1,802,471 |
| 2017-06-05 | Novo A/s (10% Owner) | Sale | 23,327 | 28.67 | 668,831 |
| 2017-03-28 | Abbvie Inc. | Sale | 450,000 | 22.50 | 10,125,000 |
| 2016-12-30 | Traweek James W Jr | Buy | 9,392 | 21.73 | 204,041 |
| 2016-12-30 | Mcgaughy R Kent Jr | Buy | 9,392 | 21.73 | 204,041 |
| 2016-12-30 | Cpmg Inc | Buy | 9,392 | 21.73 | 204,041 |
| 2016-12-16 | Traweek James W Jr | Buy | 164,753 | 22.99 | 3,787,836 |
| 2016-12-16 | Mcgaughy R Kent Jr | Buy | 164,753 | 22.99 | 3,787,836 |
| 2016-12-16 | Cpmg Inc | Buy | 164,753 | 22.99 | 3,787,836 |
| 2016-12-15 | Traweek James W Jr | Buy | 2,700 | 22.05 | 59,535 |
| 2016-12-15 | Mcgaughy R Kent Jr | Buy | 2,700 | 22.05 | 59,535 |
| 2016-12-15 | Cpmg Inc | Buy | 2,700 | 22.05 | 59,535 |
| 2016-12-14 | Traweek James W Jr | Buy | 6,189 | 21.36 | 132,227 |
| 2016-12-14 | Bass James Edward (Director) | Buy | 5,000 | 21.76 | 108,800 |
| 2016-12-14 | Mcgaughy R Kent Jr | Buy | 6,189 | 21.36 | 132,227 |
| 2016-12-14 | Cpmg Inc | Buy | 6,189 | 21.36 | 132,227 |
| 2016-08-22 | Nielsen Jack (Director) | Buy | 1,780 | 17.00 | 30,260 |
| 2016-08-18 | Traweek James W Jr | Buy | 105,562 | 17.32 | 1,828,650 |
| 2016-08-18 | Mcgaughy R Kent Jr | Buy | 105,562 | 17.32 | 1,828,650 |
| 2016-08-18 | Cpmg Inc | Buy | 105,562 | 17.32 | 1,828,650 |
| 2016-08-17 | Traweek James W Jr | Buy | 144,058 | 17.26 | 2,486,873 |
| 2016-08-17 | Mcgaughy R Kent Jr | Buy | 144,058 | 17.26 | 2,486,873 |
| 2016-08-17 | Cpmg Inc | Buy | 144,058 | 17.26 | 2,486,873 |
| 2016-08-16 | Traweek James W Jr | Buy | 58,600 | 16.21 | 949,964 |
| 2016-08-16 | Meyer Colin John (Chief Medical Officer) | Buy | 7,000 | 16.26 | 113,820 |
| 2016-08-16 | Mcgaughy R Kent Jr | Buy | 58,600 | 16.21 | 949,964 |
| 2016-08-16 | Cpmg Inc | Buy | 58,600 | 16.21 | 949,964 |
| 2016-06-30 | Traweek James W Jr | Buy | 100,000 | 19.75 | 1,975,100 |
| 2016-06-30 | Mcgaughy R Kent Jr | Buy | 100,000 | 19.75 | 1,975,100 |
| 2016-06-30 | Cpmg Inc | Buy | 100,000 | 19.75 | 1,975,100 |
| 2016-06-29 | Traweek James W Jr | Buy | 63,700 | 19.83 | 1,263,043 |
| 2016-06-29 | Mcgaughy R Kent Jr | Buy | 63,700 | 19.83 | 1,263,043 |
| 2016-06-29 | Cpmg Inc | Buy | 63,700 | 19.83 | 1,263,043 |
| 2016-06-28 | Traweek James W Jr | Buy | 900 | 19.74 | 17,763 |
| 2016-06-28 | Mcgaughy R Kent Jr | Buy | 900 | 19.74 | 17,763 |
| 2016-06-28 | Cpmg Inc | Buy | 900 | 19.74 | 17,763 |
| 2016-06-27 | Traweek James W Jr | Buy | 21,968 | 19.18 | 421,236 |
| 2016-06-27 | Mcgaughy R Kent Jr | Buy | 21,968 | 19.18 | 421,236 |
| 2016-06-27 | Cpmg Inc | Buy | 21,968 | 19.18 | 421,236 |
| 2016-06-24 | Traweek James W Jr | Buy | 51,435 | 18.92 | 973,150 |
| 2016-06-24 | Mcgaughy R Kent Jr | Buy | 51,435 | 18.92 | 973,150 |
| 2016-06-24 | Cpmg Inc | Buy | 51,435 | 18.92 | 973,150 |
| 2016-06-07 | Traweek James W Jr | Buy | 4,220 | 17.62 | 74,360 |
| 2016-06-07 | Mcgaughy R Kent Jr | Buy | 4,220 | 17.62 | 74,360 |
| 2016-06-07 | Cpmg Inc | Buy | 4,220 | 17.62 | 74,360 |
| 2016-06-06 | Traweek James W Jr | Buy | 20,000 | 17.56 | 351,200 |
| 2016-06-06 | Mcgaughy R Kent Jr | Buy | 20,000 | 17.56 | 351,200 |
| 2016-06-06 | Cpmg Inc | Buy | 20,000 | 17.56 | 351,200 |
| 2016-06-01 | John William Rose 2002 Trust (Other) | Buy | 1,100,000 | 11.00 | 12,100,000 |
| 2016-06-01 | Traweek James W Jr | Buy | 259,588 | 13.29 | 3,420,027 |
| 2016-06-01 | Huff James Warren (See Remarks) | Buy | 114,000 | 11.00 | 1,254,000 |
| 2016-06-01 | Meyer Colin John (See Remarks) | Buy | 10,000 | 11.00 | 110,000 |
| 2016-06-01 | Bass James Edward (Director) | Buy | 23,000 | 12.14 | 279,220 |
| 2016-06-01 | Mcgaughy R Kent Jr | Buy | 259,588 | 13.29 | 3,420,027 |
| 2016-06-01 | Novo A/s (10% Owner) | Buy | 750,000 | 11.00 | 8,250,000 |
| 2016-06-01 | Cpmg Inc | Buy | 259,588 | 13.29 | 3,420,027 |
Insider trading activities including stock purchases, stock sales, and option exercises of RETA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Reata Pharmaceuticals Inc (symbol RETA, CIK number 1358762) see the Securities and Exchange Commission (SEC) website.